| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -1.17% | +3.01% | -4.18% | -4.18% | — |
| 14d | 1 | +100.00% | -0.53% | +4.58% | -5.11% | -5.11% | — |
| 30d | 1 | +100.00% | -22.52% | +5.95% | -28.47% | -28.47% | — |
| 60d | 1 | +100.00% | -0.21% | +9.81% | -10.03% | -10.03% | — |
| 90d | 1 | +100.00% | -32.76% | +11.00% | -43.77% | -43.77% | — |
| 180d | 1 | +100.00% | -51.76% | +6.08% | -57.84% | -57.84% | — |
| 1y | 1 | +100.00% | -42.05% | +20.15% | -62.20% | -62.20% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 300,000 | $5.71 | $1.71M | 300,000 | Jan 30, 2026 | Feb 2, 2026 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 140,000 | $4.37 | $611.8K | 140,000 | Jan 22, 2025 | Jan 24, 2025 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | SALE10b5-1 10b5-1 plan | 20,000 | $9.50 | $190.0K | 101,957 | Sep 9, 2024 | Sep 11, 2024 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 110,000 | $3.06 | $336.6K | 110,000 | Jan 24, 2024 | Jan 25, 2024 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 26, 2023 | Jan 30, 2023 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASE Chief Scientific Officer | 1,858 | $3.72 | $6.9K | 121,957 | Aug 11, 2022 | Aug 15, 2022 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | SALE Chief Scientific Officer | 1,858 | — | — | 3,716 | Aug 11, 2022 | Aug 15, 2022 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | SALE Chief Scientific Officer | 675 | — | — | 0 | May 25, 2022 | May 27, 2022 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASE Chief Scientific Officer | 3,717 | $3.72 | $13.8K | 120,099 | May 25, 2022 | May 27, 2022 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASE Chief Scientific Officer | 675 | $0.73 | $493 | 116,382 | May 25, 2022 | May 27, 2022 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | SALE Chief Scientific Officer | 3,717 | — | — | 5,574 | May 25, 2022 | May 27, 2022 ↗ | View → |
| FHTX FOGHORN THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Jan 26, 2022 | Jan 28, 2022 ↗ | View → |